Study: Educational session effective at reducing distress in prostate cancer patients and female partners

NewsGuard 100/100 Score

In a recent study, an educational session helped alleviate distress equally in both patients with prostate cancer and their partners.

The presence of a partner at the session did not affect patients' pre- or post-session distress or the success of
the session at alleviating distress. Also, sociodemographic
and clinical characteristics had little effect on distress
levels.

For the study, 71 patients and 48 partners attended a session that provided information on prostate cancer biology and treatments, as well as the opportunity to consult with a urologist and a radiation oncologist simultaneously.

"Our education session was successful at reducing pre-treatment distress among men with prostate cancer. More than that, however, we found that the session was equally effective for partners," said Dr. Lindsay Hedden, lead author of the BJU International study. "This is critical because partners frequently experience higher levels of distress and anxiety than the men with prostate cancer themselves. Our research underscores the fact that supportive care services should be targeted not only to patients, but to their partners as well." Dr. Hedden also noted that because patients' health status is linked to that of their partners, not attending to partners' needs may be harmful to patients in the long run.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery